Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bow Capital is an early-stage venture firm (Series A and B focused) that invests at the first sign of product-market fit, primarily in the late seed through late A stages. While the firm is not a biotech, pharma, or healthcare company itself, it has a strong focus on life sciences, health, and biotech through its portfolio and unique partnership with the University of California, which provides access to a vast academic and research network. Bow Capital’s portfolio includes companies in consumer goods, manufacturing, and healthcare, with some notable investments in life science startups such as Evolve Biosystems and The Flex Company, but there is no publicly available information indicating Bow Capital itself develops therapeutic modalities, targets, or clinical-stage assets directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bow Capital.